CHICAGO, November 3, 2016 /PRNewswire/ --
Scepter Holdings, Inc. (OTC.PK: BRZL), announcedtoday the Company has signed a definitive agreement merging Scepter Holdings, Inc. with F3 Innovations, a Holding Company for Colorado Based Sports Nutrition company Intensity Nutrition.
The parties have signed a definitive agreement dated
Intensity Nutrition, a Sports Nutrition company, originally founded by an ex-Navy Seal and was recently acquired by an Industry Executive with many years experience. Intensity Nutrition is a company based in the Denver Colorado area, which in recent years has created a hotbed of MMA/UFC athletes and training centers as well as Sports Nutrition development. Intensity Nutrition products has been now been approved as a vendor on Amazon.com and an approved Vendor for Clickbank.com
F2 Innovations/dba Intensity Nutrition is excited for this transition to becoming a publicly traded company, which will help gain a larger foothold in the industry, as well as, become one of the fastest growing companies to hit the market since the likes of MusclePharm Inc. (MSLP) and Black Stone Labs to name a few.
Mr. Leonard Armenta, CEO and President of F3 Innovations/Intensity Nutrition stated: "Our success as a company and our discussions with BRZL management over these last few months has convinced us that merging with BRZL is the right move for our company to bring us into the NASDAQ OTC publicly traded arena. This will help catapult us into the next phase of our branding and public marketing campaign as well as help us bring on more qualified staff and executives to help us hit our goals for the rest of 2016 and into 2017. This move will allow us to become a major player in the industry and capture the customers that may not know us yet."
For more information on Intensity Nutrition, its brand, products, and athletes please visit http://www.intensitynutrition.com
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Scepter Holdings/ F3 Innovations/ DBA Intensity Nutrition., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Scepter Holdings/ F3 Innovations/ DBA Intensity Nutrition Inc.'s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Scepter Holdings/ F3 Innovations/ DBA Intensity Nutrition Inc.'s filings.
Media Contact: Leonard K Armenta Jr, +1-303-953-2211
SOURCE Scepter Holdings, Inc
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All